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The mechanisms of hepatocyte death and the events that lead to a high rate of chronic liver disease in patients infected
with hepatitis C virus are not known. We established a HCV replication system in HepG2 cell culture and utilized this model
to address the effect of HCV proteins on HepG2 cell growth and viability. After transfection of HepG2 cells with full-length
RNA, a truncated RNA, or an antisense RNA, cell proliferation and cell viability were analyzed by thymidine uptake and the
trypan blue exclusion method, respectively. Full-length RNA transfected HepG2 cells showed a decrease in cell proliferation
and viability compared to cells transfected with HCV truncated RNA and antisense RNA control. A subset of cells expressing
HCV proteins underwent apoptosis as documented by morphological studies, ultrastructural analysis, cell cycle analysis by
flow cytometry, terminal transferase enzyme mediated end labeling of DNA, and DNA laddering. This study suggests that
expression of HCV proteins can lead to cell death by apoptosis, which may be an important event in the pathogenesis of
chronic hepatitis C virus infection in humans. © 2001 Academic PressKey Words: hepatitis C virus; immunohistochemistry; RNA transfection; cell viability; apoptosis; TUNEL assay; electron
microscopy.INTRODUCTION
Histopathological analysis of liver biopsies from pa-
tients with chronic hepatitis C virus infection suggests
the presence of apoptotic cell death (Hiramatsu et al.,
1994). Several other RNA viruses are known to induce
apoptotic cell death, which plays an important role in
disease pathogenesis. Both measles virus (a paramyxo-
virus) and human immunodeficiency virus (a retrovirus)
cause T-cell death through apoptosis that contributes to
immunosuppression (Pignata et al., 1998; Plymale et al.,
1999). The alphaviruses Sindbis virus and Semliki Forest
virus induce apoptosis in neurons of mouse brains and
oligodendrocytes, respectively, causing encephalitis
(Nava et al., 1998; Glasgow et al., 1997). Influenza virus
(myxovirus) causes apoptosis of cultured MDCK and
U937 cells (Price et al., 1997). Dengue virus and rabies
virus induce apoptosis in a hepatoma cell line (Marin-
neau et al., 1997) and in cultured lymphocytes (Thou-
louze et al., 1997) respectively.
Hepatitis C virus (HCV) is a member of the Flaviviridae
family. Infection with HCV leads to chronic hepatitis fol-
lowed by liver fibrosis and hepatocellular carcinoma. The
HCV genome consists of a linear positive-stranded RNA
molecule of approximately 9600 nucleotides (nt) encod-
ing a single polyprotein of approximately 3010 amino
acids (Choo et al., 1989). The polyprotein is cleaved by
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26both host and viral proteases to generate three structural
proteins (core, E1, and E2) and six nonstructural proteins
(NS2, NS3, NS4A, NS4B, NS5A, and NS5B). HCV replication
occurs via synthesis of a genomic length minus-strand RNA
that serves as a replicative intermediate. At present, not
much is understood regarding the overall effect of all the
HCV proteins on cells due to the lack of a suitable in vitro
cell culture model for hepatitis C virus. Recently, our labo-
ratory has established a HCV cell culture system based
upon HCV genome length RNA transfection of a hepatoma
cell line (Dash et al., 1997). In this model, we observed
toxicity in the cells transfected with full-length HCV RNA
and a decrease in cell density over time. By using different
approaches, we report here that expression of HCV pro-
teins from transfected HCV RNA in a hepatic cell line leads
to decreased viability of the cells by apoptotic cell death.
RESULTS
Demonstration of HCV proteins in the HCV RNA
transfected HepG2 cells
The constructs used for the in vitro transcription reac-
tion are shown in Fig. 1. To confirm the expression of the
structural and nonstructural proteins of HCV in the RNA
transfected HepG2 cells and controls, immunohisto-
chemistry was performed. HepG2 cells transfected with
full-length HCV RNA expressed HCV proteins (Fig. 2).
This staining was found to be specific as demonstrated
by various controls employed in the experiment (Fig. 2).
HepG2 cells transfected with truncated HCV RNA 6.7
also expressed HCV proteins (data not shown). Immuno-
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27HCV INDUCES APOPTOSIS IN HepG2 CELLSstaining results revealed that staining for HCV proteins
was mostly in the cytoplasm. This cellular distribution of
HCV proteins is consistent with previous reports that
investigated the expression of subsets of HCV proteins
(Santolini et al., 1994; Selby et al., 1993). Approximately
0–35% of HCV RNA transfected cells were positive by
mmunohistochemistry for the HCV envelope (E2) pro-
ein. Counterstaining with hematoxylin revealed that
ome of the cells with cytoplasmic staining for HCV
roteins had condensed nuclei (Fig. 2).
CV RNA transfected HepG2 cells showed reduced
ell proliferation
The effect of HCV protein expression on cell prolifer-
tion was assayed by [3H]thymidine uptake. Dividing
cells are known to incorporate 3H-labeled thymidine in
NA, which can be estimated as an indicator of cell
roliferation. Proliferation of HepG2 cells transfected
ith full-length RNA or truncated RNA or mock trans-
ected in the presence of [3H]thymidine is shown in Fig.
. Cells transfected with only full-length RNA had re-
uced proliferation at all time points (7, 14, and 21 days)
ompared to the two controls. HepG2 cells transfected
ith truncated RNA showed reduced cell proliferation at
wo earlier time points (7 and 14 days), which returned to
he same as the mock control at 21 days. HCV 6.7 RNA
acks the NS5B region and we have previously shown
hat this construct does not replicate in cell culture. The
FIG. 1. Construct used to prepare HCV full-length and antisense R
repared by in vitro transcription using T7 RNA polymerase from pGEM
3) was prepared from the same plasmid using SP6 polymerase after
repared by in vitro transcription using T7 polymerase from pGEM
onstructural HCV proteins are expressed from full-length HCV RNA (1
f NS5A and NS5B. Antisense RNA (3) does not express any HCV proeduction in proliferation of HepG2 cells transfected with
his construct might be due to translation of proteins. To
c
tonfirm this finding, immunohistochemistry was per-
ormed on HepG2 cells transfected with full-length HCV
NA, truncated RNA, or another mutant RNA lacking the
nternal ribosomal entry site. There was a significant
ecrease in HCV-positive cells transfected with the trun-
ated RNA construct at 14 and 21 days compared to
ull-length RNA transfected cells (Fig. 4). Cells trans-
ected with the mutant RNA did not express HCV proteins
nd showed no reduction in viability. These results suggest
hat HCV protein expression appears to be responsible for
he reduction in cell proliferation and cell viability.
ransfection of HepG2 cells with HCV RNA leads to
educed viability
There was a decrease in the viability of HepG2 cells
ransfected with full-length HCV RNA compared to anti-
ense RNA or mutant RNA transfected cells (Fig. 5A).
elative to mock-transfected cells, full-length HCV RNA
ransfected cells showed a 30% reduction in cell viability.
ells transfected with mutant RNA lacking the HCV in-
ernal ribosomal entry site (508–9565 mutant) did not
xpress HCV proteins (Fig. 4) and failed to show a
eduction in cell viability (Fig. 5A). To determine whether
imilar results could be obtained with other HCV clones
ncluding clones shown to be infectious in vivo, HepG2
ells were transfected with RNA transcribed from a chim-
anzee infectious clone, pCVJ4L6S (Yanagi et al., 1998),
nd cell viability was determined. The viability of HepG2
in vitro transcription. Full-length HCV RNA 9565 nt in length (1) was
7 after restriction digestion with HindIII. Antisense HCV RNA (9100AS)
ion with NotI. Similarly truncated HCV RNA 6700 nt in length (2) was
after restriction digestion with EcoRI enzyme. All the structural and
eas truncated HCV RNA (2) encodes all the HCV proteins except part
he positions of the restriction sites are shown in the figure.NA by
9.6-T
digest
6.7-T7ells transfected with RNA derived by in vitro transcrip-
ion of the infectious clone was also reduced by 37%
m
o
u days,
i
28 KALKERI ET AL.compared to the mock transfected control. To ascertain
whether this effect was due to expression of HCV pro-
teins from transfected RNA or replication of RNA, HepG2
cells were transfected with HCV cDNA from a mamma-
lian expression plasmid (pcDNA3/333-9425). Interest-
FIG. 2. Demonstration of HCV envelope (E2) protein in the transfec
(arrows) in full-length HCV RNA transfected HepG2 cells (3400). Inset
HCV RNA transfected HepG2 cells stained with preadsorbed anti-E2 an
(3400). (D) Full-length HCV RNA transfected HepG2 cells stained with
FIG. 4. Expression of HCV proteins in HepG2 cells transfected with
utant RNA lacking the internal ribosomal entry site and translational
r HCV full-length RNA (HCV 9.6) (C), at different time points posttransfe
nder Materials and Methods (I, 7 days; II, 14 days; III, 21 days). At 21
n the full-length RNA transfected cells.ingly, we observed a similar reduction (30%) in cell via-
bility of HepG2 cells transfected with this construct.To correlate reduction in viability of transfected cells
with the amount of HCV RNA, increasing amounts of HCV
RNA were used for transfection. As shown in Fig. 5B, a
progressive decrease in cell viability was observed, from
75.4% viable cells for 1 mg of HCV RNA to 63.22% viable
pG2 cells and controls. (A) Expression of HCV envelope (E2) protein
a positive HepG2 cell with condensed nucleus (31000). (B) Full-length
3400). (C) Mock-transfected HepG2 cells stained with anti-E2 antibody
l mouse IgG (3400).
ull-length RNA and controls. HepG2 cells were transfected with HCV
don (HCV 508-9565 mutant) (A), or HCV truncated RNA (HCV 6.7) (B),
ollowed by immunohistochemistry using anti E2 antibody as described
fewer cells were positive in the truncated RNA transfected cells thanted He
shows
tibody (
norma
HCV f
start co
ction fcells for 6 mg of HCV RNA. The overall levels of HCV
protein production were proportional to the amount of
a
u
i
(
D
terials a
ne blue
29HCV INDUCES APOPTOSIS IN HepG2 CELLSHCV RNA transfected (data not shown). These results
indicated that HCV protein expression resulted in de-
creased viability of HepG2 cells and that this effect was
dose dependent. To confirm the finding that altered cell
viability is due to the expression of HCV proteins, an
additional experiment was performed with three different
constructs, HCV full-length RNA, HCV truncated RNA,
and mutant RNA lacking the HCV internal ribosomal
FIG. 6. Fragmentation of DNA in the transfected HepG2 cells shown
nd subjected to TUNEL assay. (B) HepG2 cells transfected with full-le
sing a TACS Assay kit (Genzyme, Inc.), followed by diaminobenzidine
n the nucleus show dark brown staining (arrows). 1% methyl green w
FIG. 7. Fragmentation of DNA in the transfected cells by propidium i
A) or antisense RNA (9100 AS) of HCV stained with propidium iodide
NA is seen only in the full-length RNA transfected cells.
FIG. 8. Toluidine blue staining of EM thick sections showing nuclear c
transfected with antisense RNA and (B) HepG2 cells transfected with
toluidine blue and paraphenylediamine staining as described under Ma
morphology. Cells with condensed nuclei are stained dark with toluidientry site (mutant RNA). The results shown in Fig. 5C
indicate that RNA that does not express HCV proteins didnot affect cell viability compared to mock control at 3, 7,
14, and 21 days posttransfection, whereas cells trans-
fected with the other two constructs expressed proteins
and cell viability was affected.
TUNEL (terminal deoxynucleotidyltransferase
mediated dUTP–biotin nick end-labeling) assay
EL assay. (A) HepG2 cells transfected with antisense control (9100 AS)
CV RNA and subjected to TUNEL assay. Cells were labeled with TdT
onstrate fragmented DNA in the nucleus. Cells with fragmented DNA
d as a counterstain.
taining. HepG2 cells transfected with either full-length RNA (HCV 9.6)
ribed under Materials and Methods. Arrows indicate that fragmented
ation. Electron micrograph of transfected HepG2 cells. (A) HepG2 cells
ull-length RNA. Cells were fixed with 3% glutaraldehyde followed by
nd Methods. Cells were observed under a light microscope for cellular
(arrows).by TUN
ngth H
to dem
as use
odide s
as desc
ondens
HCV fAn important feature of apoptotic cell death is the
presence of fragmented DNA in the chromatin. There-
midine as described under Materials and Methods. Averages of three
d
r
mg RNA and control were assayed by trypan blue exclusion for percentage via
9.6) RNA, truncated RNA (HCV 6.7), and IRES(2) mutant HCV RNA at differen
30 KALKERI ET AL.fore, we examined HCV RNA in the transfected HepG2
cells, for DNA fragmentation by terminal transferase en-
zyme (TdT) labeling (Fig. 6). Antisense RNA transfected
HepG2 cells served as negative control. As shown in Fig.
6, about 10% of cells were TUNEL positive. Cells trans-
fected with antisense RNA and mock controls were neg-
ative. This was further confirmed using an alternative
approach to detect DNA fragmentation: cells were
stained with propidium iodide. Typical chromatin con-
densation and fragmentation characterizing apoptotic
cells were evident in HCV full-length RNA transfected
HepG2 cells (Fig. 7).
Morphological and ultrastructural studies
HCV RNA transfected cells were processed for trans-
mission electron microscopy to confirm morphological
changes during apoptosis such as nuclear condensa-
ontrols. (A) Cell viability of HepG2 cells transfected with different HCV
y compared to controls. HepG2 cells (1 3 105) were transfected with
pan blue dye exclusion for percentage viability. (B) Dose-dependent
105) transfected with different doses of HCV RNA ranging from 0 to 6FIG. 3. Cell proliferation of HCV RNA transfected cells compared to
controls at different time points posttransfection. HepG2 cells were
transfected in 12-well plates in triplicate with HCV full-length RNA (HCV
9.6) or HCV truncated RNA (HCV 6.7) or were mock transfected. At
different time points posttransfection, cells were labeled with [3H]thy-experiments are shown with standard error bars.
FIG. 5. Cell viability studies of HepG2 cells transfected with HCV RNA and c
RNAs and cDNAs. Cells transfected with HCV RNA have reduced cell viabilit
ifferent constructs of HCV RNA and cDNA in triplicate and assayed by try
elationship between HCV full-length RNA and cell viability. HepG2 cells (1 3bility. (C) Cell viability of HepG2 cells transfected with full-length (HCV
t time points posttransfection.
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31HCV INDUCES APOPTOSIS IN HepG2 CELLStion, nuclear fragmentation, and cell shrinkage. One to
2-mm-thick sections of cell pellets were stained with
oluidine blue and paraphenylediamine and then exam-
ned by light microscopy for differentiation of nuclear
orphology and cytoplasmic compartments. Ten to 15%
f cells transfected with full-length HCV RNA showed
uclear condensation (Fig. 8B), as evidenced by darker
taining nuclei when compared with controls (Fig. 8A) by
andom unbiased counting. These pellets were further
ubjected to transmission electron microscopy to study
he ultrastructural changes. Cells with nuclear conden-
ation and fragmentation of nuclei but with intact cyto-
lasmic organelles and plasma membranes (shown in
ig. 9A) were seen, compared to control cells (Fig. 9B).
hese morphological changes were suggestive of apo-
tosis. Morphological changes characteristic of apopto-
is were not observed in HepG2 cells transfected with
ntisense RNA or mock-transfected controls.
ell cycle analysis
The presence of apoptotic cells in the HCV RNA trans-
ected cell cultures was further confirmed by flow cytom-
try. Hypodiploid DNA peaks in the sub-G0/G1 region
ere detected in propidium iodide stained HepG2 cells
ransfected with HCV RNA. Antisense RNA transfected
epG2 cells did not show a sub-G0/G1 peak, indicating
he absence of apoptotic cells (Figs. 10A and 10B). Ap-
roximately 10% of the HCV transfected cells were found
o be apoptotic.
NA fragmentation
Apoptotic cells are characterized by the presence of
FIG. 9. Ultrastructural changes characteristic of apoptosis in HCV
fragmented nucleus. (B) Control RNA transfected cell showing no such
under a transmission electron microscope.ragmented DNA in their nucleus. This fragmented DNA
an be extracted and analyzed on 2% agarose gels.
c
fecrotic cells are characterized by the presence of a
NA smear, whereas apoptotic cells have fragmented
NA. To confirm the apoptotic changes of HCV RNA
ransfected cells; we evaluated DNA laddering of full-
ength, truncated, and mock transfected cells (Fig. 11).
owever, a moderate DNA ladder was present in HCV
.7 RNA transfected cells, thus confirming our earlier
bservation that reduced cell viability in HCV 6.7 RNA
ransfected cells was due to the expression of HCV
roteins.
DISCUSSION
Histochemical examinations of biopsy samples from
atients with hepatitis C have been reported to show
poptosis of hepatocytes (Kerr et al., 1979; Calabrese et
l., 2000). It is not clear whether these apoptotic bodies
re due to direct the cytopathic effect of HCV or a
onsequence of immunological reactions. To investigate
he former hypothesis, we determined the effects of HCV
rotein expression on hepatic cells. Since HCV is a
epatotropic virus, we used a hepatoblast cell line to
tudy the effects of HCV expression on cells. Previously
e had reported that transfection of full-length HCV RNA
o HepG2 cells leads to replication and formation of
nfectious viral particles in cell culture. We observed that
ells transfected with HCV RNA showed significant cy-
otoxicity and a decrease in cell density over time. In this
eport, we extended these observations and determined
he effect of HCV expression on cell viability. To exclude
oxicity associated with RNA transfection, an antisense
NA and a mutant RNA lacking the internal ribosomal
ntry site were used as controls. We demonstrated that
epG2 cells transfected with full-length as well as trun-
transfected cells. (A) Full-length HCV RNA transfected cell showing
s. Transfected cells were fixed with glutaraldehyde and then observedRNAated HCV 6.7 RNA produced HCV proteins after trans-
ection. A small proportion (30–35%) of these cells
jected
32 KALKERI ET AL.showed distinct cytoplasmic positive staining as de-
tected by immunohistochemistry using specific anti-HCV
protein antibodies. Some of the cells expressing HCV
proteins had condensed nuclei, a characteristic feature
of apoptotic cell death (Garen et al., 1999; Price et al.,
1997; Hoff and Donis, 1997). We have also confirmed the
expression of all the structural and nonstructural pro-
FIG. 10. Cell cycle analysis of transfected HepG2 cells by flow cyto
cells transfected with HCV full-length RNA (HCV 9.6). Cells were sub
hypodiploid (,2n) DNA, as they appeared in the sub-G0/G1 peak.
FIG. 11. Demonstration of DNA laddering in HCV RNA transfected
HepG2 cells. Mock transfected cells (lane 2), and cells transfected with
HCV 9.6 RNA (lane 3), 6.7 RNA (lane 4), and antisense (9100 AS) RNA
(lane 5) were subjected to DNA laddering. Lane 1, 100-bp molecular
weight marker. The brighter band in the molecular weight marker lane
is 600 bp. Fragmented nuclear DNA in HCV full-length RNA transfected
cells can be seen as a brighter DNA ladder, compared to a faint ladder
in truncated RNA transfected cells.teins of HCV from the cDNA construct used in the
present study (Myung et al., in press) manuscript sub-
mitted for publication). We showed that cells transfected
with full-length HCV RNA affected cell viability and cell
proliferation at 7, 14, and 21 days after transfection.
HepG2 cells transfected with mutant RNA had a similar
effect at the earlier time point possibly because this RNA
may still translate protein. To confirm these observations,
expression of HCV protein in the transfected cells was
examined at 7, 14, and 21 days. As expected, cells trans-
fected with full-length as well as mutant HCV RNA 6.7
express HCV protein at 7, 14, and 21 days. However,
there are many fewer HCV-positive cells present in the
6.7 RNA transfected cells compared to full-length RNA
(Fig. 4, B3). The decrease in proliferation of cells trans-
fected with truncated RNA at earlier time points (7 and 14
days) might be due to the expression of HCV proteins,
but these cells recovered at 21 days probably because of
the absence of HCV protein expression (Fig. 4). It is of
interest to note that there is a reduction of cell viability at
14 and 21 days. This is probably due to the fact that not
all HepG2 cells in the culture were transfected uniformly
with HCV RNA. Cells transfected with many copies of
HCV RNA translated more HCV protein and became
positive by immunocytochemistry and exhibited reduced
cell viability at earlier time points. However, cells trans-
fected with fewer copies of HCV RNA may not have been
detected at earlier time points by immunocytochemistry
possibly due to lower levels of HCV protein expression.
We feel that the replication and translation of HCV RNA
in these cells over time led to the accumulation of HCV
A) HepG2 cells transfected with antisense RNA (9100 AS). (B) HepG2
to flow cytometry. 10% of HCV full-length RNA transfected cells hadmetry. (proteins that affected cell viability on days 14 and 21.
Reduction in cell viability was not exclusively due to
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33HCV INDUCES APOPTOSIS IN HepG2 CELLSreplication of transfected RNA since similar toxicity was
observed in cells that were transfected either with a
truncated HCV RNA control (Fig. 5) or with a pcDNA3/
333-9425 construct lacking the 59UTR and parts of the
39UTR at 3 days posttransfection, both presumably rep-
lication defective. This effect might be due to translation
of HCV proteins by this construct. To support this as-
sumption, we performed additional experiments and de-
termined that cells transfected with HCV RNA with a
deletion of internal ribosome entry site sequences did
not produce proteins and had no effect on cell viability
(Fig. 5). To exclude the possibility that the reduction in
cell viability in HCV RNA transfected cells might be due
to the nonspecific effect of transfected RNA, cells trans-
fected with antisense RNA and mutant RNA with a dele-
tion in the internal ribosomal entry site were used as
controls. Cells transfected with these RNAs did not show
reduced cell viability. These results suggest that expres-
sion of HCV proteins is toxic to cells.
To determine whether HepG2 cells expressing HCV
proteins had morphological features of apoptosis, DNA
fragmentation, cell cycle analysis, TUNEL assays, and
electron microscopy studies were performed. Cells
showing evidence of apoptosis were observed in a HCV
RNA transfected HepG2 cell culture by different assays
and compared to control cultures. To further characterize
the ultrastructural changes in these cells, high-magnifi-
cation transmission electron microscopy was performed
and cells with fragmented and crescent-shaped nuclei,
but with intact cytoplasmic organelles and membranes
characteristic of apoptotic cell death were observed (Fig.
8). TUNEL assays and cell cycle analysis provided fur-
ther evidence of apoptotic cell death, because of the
appearance of a brown staining nucleus (Fig. 6) and a
sub-G0/G1 peak (Fig. 10), respectively. There is a differ-
ence in DNA fragmentation in cells transfected with
full-length versus truncated HCV RNA. This difference
could be due to a combination of RNA replication, RNA
stability, translation, and persistence of full-length RNA
compared to truncated HCV 6.7 RNA. It is interesting to
note that though about 30–35% of transfected cells ex-
pressed HCV proteins, only 10–15% of the cells under-
went apoptosis. This discrepancy demonstrates a differ-
ence in various assays employed to assay cell death.
[3H]Thymidine uptake measures cell proliferation and
rypan blue dye exclusion measures membrane perme-
bility changes, whereas cell cycle analysis and DNA
addering measure hypodiploid DNA and fragmented
NA, respectively.
The apoptotic form of cell death is reported in many
ther virus infections in vitro as well as in vivo. This
ccurs either due to toxic effects of viral proteins or due
o host–virus interactions. At present there are several
eports representing both pro- and anti-apoptotic effects
f HCV proteins. Most of these studies have relied on
ystems that express either individual proteins of HCV
b
ccore, NS3) or systems in which only a few HCV proteins
ere expressed in cells. Some of these reports indicate
hat core protein expression induced apoptosis in re-
ponse to anti-fas monoclonal antibody (Ruggieri et al.,
997) and enhanced the susceptibility of hepatocytes to
NFa mediated apoptosis (Zhu et al., 1998). Some re-
orts indicate that expression of HCV core protein sup-
resses c-myc overexpression induced apoptosis in Chi-
ese hamster ovary cells, cisplatin mediated apoptosis
n human cervical epithelial cells (Ray et al., 1996), and
NFa induced apoptosis in a human breast carcinoma
cell line (Ray et al., 1998). Marusawa et al. (1999) re-
ported inhibition of TNFa and fas mediated apoptosis of
HepG2 cells via NF-kB activation by HCV core protein.
ctivation of NF-kB is shown to be responsible for the
resistance of hepatic cells expressing HCV structural
proteins to TNFa (Tai et al., 2000). Fujita and co-workers
1996) suggested that NS3 protein inhibits actinomycin D
nduced apoptosis in NIH 3T3 cells. Expression of NS5A
rotein in HepG2 cells is also shown to protect against
NFa induced apoptosis (Ghosh et al., 2000). In contrast,
umoulin and co-workers (1999) have shown that HCV
ore protein does not inhibit apoptosis in HepG2 cells
nduced by either TNFa or fas. However, some other
eports have suggested proapototic effects of HCV pro-
ein expression. An osteosarcoma cell line inducibly ex-
ressing both structural and nonstructural proteins of
CV exhibited cytotoxicity (Moradpour et al., 1998). Chi-
nese hamster ovary cells stably expressing core protein
were shown to undergo apoptosis in response to serum
starvation (Honda et al., 2000). Thus, both anti-apoptotic
and pro-apoptotic effects of HCV proteins are evident. It
is possible that the effects of HCV proteins on the cells
might be different depending upon whether HCV pro-
teins are expressed alone or in the presence of other
HCV proteins. Differences in these contradicting reports
about the pro- and anti-apoptotic effects of HCV proteins
might also be due to the different cell lines and HCV
proteins used. To mimic the in vivo HCV infection, in
which all the HCV proteins are present, we used full-
length HCV RNA and cDNA transfection. Though it was
recently reported that replication of HCV might be re-
sponsible for liver injury (Chang et al., 2000), toxicity
associated with HCV truncated 6.7 RNA and HCV cDNA
(pcDNA3/333-9425) expression in our experiments indi-
cates that reduction in cell viability is due to HCV protein
expression. The circumstances in which these events
are relevant and their role in virus infection in vivo and in
ellular transformation need to be studied in detail.
Several unsuccessful attempts by different laborato-
ies including ours have been made to establish stable
ell lines for full-length HCV genome. This may be partly
elated to the cytotoxicity associated with the expression
f HCV proteins. We have observed apoptosis induced
y the expression of HCV proteins in a hepatic cell
ulture model. Currently we are investigating which
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34 KALKERI ET AL.structural or nonstructural HCV proteins induce apopto-
tic cell death in HepG2 cells. This will allow us to under-
stand the mechanism of host–virus interactions in HCV
induced apoptotic cell death. Further studies of the rel-
evance of apoptosis in HCV infections in humans are
needed.
MATERIALS AND METHODS
Plasmid constructs
The full-length HCV cDNA clone used in this study has
been described previously (Dash et al., 1997). Full-length
CV RNA was prepared from this construct using T7
NA polymerase. It was not possible to prepare an
ntisense RNA from the plasmid construct pMO9.6-T7
ince this plasmid construct does not have an SP6 pro-
oter or a T7 promoter in the opposite orientation.
herefore, another construct, pGEM 9.6-T7, was pre-
ared. For this purpose, we first removed the full-length
CV cDNA from pMO9.6-T7 by HindIII digestion and
loned it into the pGEM 3Zf(1) vector. This allowed us to
enerate an antisense RNA from HCV cDNA using SP6
NA polymerase. To generate run-off transcripts, this
lasmid was linearized with NotI enzyme, and antisense
NA was prepared using SP6 RNA polymerase. To gen-
rate HCV truncated 6.7 RNA, pGEM6.7-T7 was restric-
tion digested with EcoRI enzyme followed by in vitro
transcription using T7 RNA polymerase. Full-length HCV
RNA was prepared from an infectious clone, pCVJ4L6S,
which was obtained as a gift from Jens Bukh, NIH, using
XbaI digestion (Yanagi et al., 1998). We prepared an
expression plasmid construct, pcDNA3/333-9426, to ex-
press all the HCV proteins. For this purpose, we PCR
amplified nt 333–628 of the pMO9.4 clone using primers
59CCGTGCATCATGAGCACAATCCAAAACC39 (sense)
and 59CAAGCCCTCATTGCCATAG39 (antisense). The
PCR product was restriction digested with NotI and
cloned into pMO9.4-T7 plasmid. The HindIII fragment
from this construct containing HCV nt 333–9425 se-
quence was again recloned into the mammalian expres-
sion vector pcDNA3. This construct does not contain the
59 UTR and has only 50 nucleotides of the 39UTR. The
resultant plasmid, pcDNA3/333-9425, was used for trans-
fection of HepG2 cells using FuGene6 (Roche, Indianap-
olis, IN) transfection reagent, according to the manufac-
turer’s protocol. cDNA for HCV mutant RNA was pre-
pared by restriction digestion of pMO9.6-T7 with NotI and
HindIII enzymes followed by cloning into pGEMEX 2.0
(Promega Inc., Madison, WI). This clone lacks the first
508 bp of HCV cDNA encoding the 59UTR and internal
ribosomal entry site. Mutant RNA was prepared by using
HindIII linearized pGEMEX 508-9565 as a template in the
in vitro transcription reaction.Preparation of HCV RNA transcripts
Sense and antisense HCV RNA was prepared from
plasmid construct pGEM 9.6-T7 using T7 and SP6 RNA
polymerase, respectively (Promega). Mutant HCV RNA
was prepared using T7 RNA polymerase from HindIII
linearized pGEMEX 508-9565. HCV RNA was in vitro
transcribed using 40 mmol/L Tris/HCl (pH 7.5), 6 mmol/L
MgCl2, 10 mmol/L dithiothreitol, 2.5 mmol/L ribonucleoti-
es, and 5 mg of DNA templates. The reaction mixture
as incubated for 1 h at 37°C. Next the reaction mix was
reated with DNase I (RQ1 DNase, Promega) for 1 h and
final phenol:chloroform extraction was performed. A
econd DNase digestion was performed to ensure no
arryover of DNA in the in vitro transcripts. The RNA was
xtracted with phenol:chloroform and then with chloro-
orm:isoamyl alcohol. Finally the RNA transcripts were
recipitated with 2.5 vol of absolute ethanol after 1 vol of
.5 mol/L ammonium acetate was added. The integrity of
he RNA transcripts was evaluated after electrophoresis
hrough a 1% agarose gel.
ell culture and RNA transfection
HepG2 cells were obtained from the American Type
ulture Collection (Rockville, MD) and maintained in min-
mal essential medium (MEM; Gibco BRL) with 10% fetal
ovine serum, sodium pyruvate, nonessential amino ac-
ds, and antibiotics. HepG2 cells are well-differentiated
ells with biosynthetic capabilities similar to those of
uman hepatocytes. Separate 60-mm dishes of HepG2
ells (2 3 106 cells) seeded 1 day before transfection
were transfected with 20 mg of HCV RNA, antisense
NA, HCV 6.7 RNA or mock transfected using the dieth-
lamino-ethyl (DEAE)–dextran method. For this purpose
complex of DEAE–dextran (400 mg) and 20 mg of HCV
RNA in 0.5 ml of 10 mmol/L HEPES buffer, pH 7.3, was
incubated. After 30 min 0.5 ml of complete medium was
added to the complex and layered on HepG2 cells in
60-mm dishes for 2 h. Finally the complex was removed,
and the cells were washed three times with 5 ml of PBS
and treated for 2 min with 2 ml of PBS containing 10%
dimethyl sulfoxide. The cells were then washed and
maintained in 3 ml of complete medium.
Immunohistochemistry of HCV proteins
We determined whether HCV RNA transfected HepG2
cells produced HCV proteins by immunohistochemistry
using anti-E2 antibody (gift from Michael Houghton, Chi-
ron Corp., Emeryville, CA) and the ABC method (Vec-
tastain, Vector Laboratories, Burlingame, CA). Since de-
tection of HCV proteins is very critical in this system, we
first determined the specificity of anti-E2 antibody based
upon following evidence: (i) Anti-E2 antibody reacted in
both Western blotting and immunofluorescence assays
using a vaccinia–T7 binary expression system that ex-
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35HCV INDUCES APOPTOSIS IN HepG2 CELLSpresses HCV proteins; (ii) preadsorption of anti-E2 anti-
body with HCV positive cells followed by immunostaining
of HCV RNA transfected cells revealed a negative reac-
tion; and (iii) there was a linear correlation between the
amount of HCV RNA used for transfection and the num-
ber of positive cells detected by immunohistochemistry.
At 3 days after transfection, immunohistochemistry for
HCV was performed. After the cells were washed twice
with phosphate-buffered saline (PBS), pH 7.4, cells were
air-dried and fixed with cold acetone (Fisher Scientific,
Pittsburgh, PA) for 10 min. The cells were permeabilized
with 0.05% saponin after being rinsed with PBS thrice for
5 min each. Blocking of these cells was performed with
1.5% normal goat serum (Sigma Chemical Co., St. Louis,
MO) and 2% BSA for 30 min at room temperature. The
cells were incubated with primary antibodies (1:500)
overnight at 4°C. Negative controls with 1:500 normal
mouse IgG (Biotechnology Inc., Santa Cruz, CA) were
used instead of primary antibody. After being rinsed with
PBS, the slides were incubated with biotinylated goat
anti-mouse antibody (Biotechnology Inc., Santa Cruz,
CA). Blocking for endogenous biotin and peroxidase was
done with 0.9% H2O2 for 30 min followed by Elite avidin–
iotin peroxidase complex (Vector Laboratories, Burlin-
ame, CA). The slides were developed by incubation
ith diaminobenzidine (Dako, Carpinteria, CA) for 1 min.
ounterstaining was done with hematoxylin (Sigma
hemical Co.) for 1 min. The slides were mounted with
ermount after dehydration and observed under an
lympus light microscope.
ell proliferation
Cell proliferation was measured by [3H]thymidine up-
take by using a standard protocol published previously
(Tolleson et al., 1996). HepG2 cells transfected with HCV
RNA and controls at different time points were incubated
with 0.1 mCi [3H]thymidine for 4 h in MEM with 10% fetal
bovine serum. Cells were washed once with PBS and
10% trichloroacetic acid (TCA). Cells were then incubated
with 10% TCA for 10 min at 37°C. After TCA was removed
from the cell culture plates, cells were lysed with 0.5 ml
of lysis buffer containing 0.33 N NaOH and 1% sodium
dodecyl sulfate. The cell lysates were then mixed with 6
ml of scintillation fluid and [3H]thymidine incorporation
as measured in a liquid scintillation counter (Beckman
nstruments, Fullerton, CA).
ell viability
HepG2 cells transfected with HCV RNA and controls
ere subjected to cell viability assays using a standard
rypan blue dye exclusion assay at 3 days posttransfec-
ion as indicated. Transfected cells were trypsinized and
esuspended in 1 ml of complete minimal essential me-
ium. Twenty microliters of this solution was mixed with
0 ml of PBS and 50 ml of 0.4% trypan blue (SigmaChemical Co.) and incubated at room temperature for 1
min. Live and dead cells were observed and counted in
the neubar’s chamber. The number of dead cells was
counted as those stained with trypan blue dye within four
microscopic fields of neubar’s slide. The percentage of
total cells excluding the dye is expressed as the percent-
age viability. The percentage viability of mock transfected
cells was taken as 100% and other results were normal-
ized.
TUNEL assay
The TUNEL technique detects endonucleolytically
cleaved DNA by the addition of labeled dUTP to DNA
ends by TdT. HepG2 cells transfected with full-length
HCV RNA and controls were used for the TUNEL assay
using a TACS in situ apoptosis detection kit (Genzyme
nc., Cambridge, MA) according to the manufacturer’s
rotocol. The cells were counterstained with 1% methyl
reen followed by observation under a light microscope.
bjective analysis of TUNEL stained cells was per-
ormed by the method previously reported (Plymale et al.,
995). Propidium iodide staining was performed by add-
ng propidium iodide to 1 3 105 cells to a final concen-
tration of 10 mg/ml followed by fluorescence microscopy.
Morphological and ultrastructural studies
HepG2 cells transfected with full-length HCV RNA and
antisense RNA controls were examined at 3 days post-
transfection by electron microscopy. Pellets of the trans-
fected and control HepG2 cells were fixed in 3% glutar-
aldehyde, postfixed in 1% osmium tetroxide, dehydrated
in ethanol, infiltrated with propylene oxide, and embed-
ded in Epon mixture. To determine the percentage of
apoptotic cells, thick sections of the pellet (1–2 mm) were
fixed on a glass slide and stained with toluidine blue (TB)
(Fisher Scientific) and paraphenyldiamine (PDA). A mix-
ture of TB and PDA differentially stains cytosolic and
nuclear compartments. The slides were then washed
with warm water, air-dried, and examined with a light
microscope for cellular morphology. Ten high-power
fields were randomly examined in the control as well as
HCV transfected cells and changes were recorded. For
transmission electron microscopy, ultrathin sections
were stained with a saturated solution of uranyl acetate
and lead citrate. Cell pellets were examined by transmis-
sion electron microscopy using a Hitachi H.7100 electron
microscope without knowledge of the origin of the cells.
Flow cytometry
For flow cytometry analysis of HepG2 cells transfected
with HCV RNA and controls, cells were washed with PBS
twice, trypsinized, and resuspended in 200 ml of PBS.
These cells were fixed with 70% ethanol. After incubation
at 4°C for 30 min, cells were again washed twice with
PBS. To remove double-stranded RNA, cells were further
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36 KALKERI ET AL.incubated with 3 units of RNase for 30 min at 37°C,
followed by staining with 100 ml of propidium iodide
Roche Molecular Biochemicals, Indianapolis, IN) for 10
in and 10,000 cells were analyzed in an EPICS-Elite
low cytometer (Coulter, Hialeah, FL).
NA fragmentation
Apoptosis of HCV RNA transfected HepG2 cells was
onfirmed by a DNA laddering assay. A total of 5 3 105
HepG2 cells transfected with RNA and controls were
mixed with 20 ml lysis buffer [20 mM EDTA, 100 mM Tris,
pH 8.0, 0.8% (w/v) SDS] and 10 ml RNase A/T1 cocktail
ix (500 units/ml and 20,000 units/ml, respectively from
mbion Inc.) and incubated at 37°C for 60 min. Ten
icroliters of proteinase K (20 mg/ml, Ambion Inc.) was
hen added to the cell lysates followed by incubation at
0°C for 90 min. Five microliters of 63 DNA loading
uffer was added to the lysates and electrophoresed on
.5% agarose gel in 13 Tris–acetate–EDTA buffer at 35 V
or 4 h.
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